Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "UK government's Department"


3 mentions found


The finance and insurance sector is the most exposed to the adoption of AI. The report found jobs in finance, law, and business management were likely to be impacted by AI. AdvertisementA new report that measures AI's effect on London city workers may raise alarm bells on Wall Street. "The finance & insurance sector is more exposed to AI than any other sector," the report said. Here are the top ten UK sectors with the highest exposure to AI:Advertisement
Persons: Organizations: UK government's Department for Education, Service, UK government's Department, Education's Unit Locations: London
The UK's AI summit is underway. Some AI experts and startups say they've been frozen out in favor of bigger tech companies. They warn that the "closed door" event risks ensuring that AI is dominated by select companies. The UK's AI summit aims to bring together AI experts, tech bosses, and world leaders to discuss the risks of AI and find ways to regulate the new technology. "It is far from certain whether the AI summit will have any lasting impact," Ekaterina Almasque, a general partner at European venture capital firm OpenOcean, which invests in AI, told Insider.
Persons: Elon Musk, Sam Altman, , OpenAI's Sam Altman, Brad Smith, Kamala Harris, Iris Ai, Victor Botev, Yann LeCun, Rishi Sunak, Ekaterina Almasque, Almasque, Goldman Sachs Organizations: Service, OpenAI's, Microsoft, Twitter, UK, Big Tech, UK government's Department for Science, Innovation, Technology, UK's Trades Union Congress, American Federation of Labor, Industrial Organizations, Summit Locations: OpenOcean
LONDON, March 2 (Reuters) - Drugmaker Viatris Inc (VTRS.O) warned on Thursday that it will stop selling some essential medicines in the UK that are already in short supply unless the British government makes changes to its voluntary medicines pricing agreement. If that level is exceeded, the government recoups the excess from suppliers of branded drugs. His colleague Viatris' Head of Europe Artur Cwiok named Germany and Portugal as countries where governments were weighing changes to drug pricing. If Viatris opted to leave that pricing scheme, it would have to pay a rate in the statutory scheme the government says will rise to 27.5%. Pharma companies AbbVie Inc (ABBV.N) and Eli Lilly and Co (LLY.N) withdrew from the pricing scheme in January.
Total: 3